European Research Infrastructure Consortia (ERICs) provide unparalleled access to world-class facilities, expertise, and data across Europe, enabling researchers to accelerate and de-risk the translation of biomedical discoveries into practical health solutions. By connecting academia, industry, and innovation ecosystems, ERICs play a critical role in moving ideas from the lab towards real-world impact.
In this webinar, Bahne Stechmann, Deputy Director of EU-OPENSCREEN, will introduce the EU-OPENSCREEN research infrastructure and its role in chemical biology and early drug discovery. Drawing on his background in academia and biotechnology, Bahne will outline how EU-OPENSCREEN’s pan-European network supports compound screening, medicinal chemistry, and collaborative projects, while also addressing opportunities and challenges for university spin-outs.
The session will conclude with Cansu Tekin presenting EATRIS, a non-profit European research infrastructure that provides access to expertise and facilities from over 175 leading academic centres. Cansu will explain how EATRIS supports the optimisation of preclinical and early clinical development of drugs, vaccines, and diagnostics, helping innovators overcome translational barriers through tailored scientific, strategic, and innovation support.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
ASTP's conference helped us to network with decision-makers in the technology transfer industry and provides a great platform to discuss future innovation in this sector.
Christopher Römer
Inventtory, Germany
I am happy to be able to share my own experiences with other colleagues via various courses, and I enjoy every moment I can spend in this network. Proud to be part of the ASTP community!
Paul van Dun
KU Leuven, Belgium
ASTP Annual conference is a unique opportunity to take time to exchange best practices among TT professionals and to network at an EU level.
Cécile Cavalade
ULB TTO, Belgium
The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!
Ilse Sienaert
KU Leuven R&D, Belgium
The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.
Ram Siddappa
Erasmus MC, Netherlands
Join our newsletter and get the latest news